ATE515579T1 - Hpv-e6-, -e7-mrna-test und verwendungsverfahren dafür - Google Patents

Hpv-e6-, -e7-mrna-test und verwendungsverfahren dafür

Info

Publication number
ATE515579T1
ATE515579T1 AT06734312T AT06734312T ATE515579T1 AT E515579 T1 ATE515579 T1 AT E515579T1 AT 06734312 T AT06734312 T AT 06734312T AT 06734312 T AT06734312 T AT 06734312T AT E515579 T1 ATE515579 T1 AT E515579T1
Authority
AT
Austria
Prior art keywords
hpv
assay
mrna
cell
malignant
Prior art date
Application number
AT06734312T
Other languages
English (en)
Inventor
Bruce K Patterson
Original Assignee
Bruce K Patterson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36579843&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE515579(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bruce K Patterson filed Critical Bruce K Patterson
Application granted granted Critical
Publication of ATE515579T1 publication Critical patent/ATE515579T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06734312T 2005-02-02 2006-02-02 Hpv-e6-, -e7-mrna-test und verwendungsverfahren dafür ATE515579T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/050,384 US7524631B2 (en) 2005-02-02 2005-02-02 HPV E6, E7 mRNA assay and methods of use thereof
PCT/US2006/003885 WO2006084155A1 (en) 2005-02-02 2006-02-02 Hpv e6, e7 mrna assay and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE515579T1 true ATE515579T1 (de) 2011-07-15

Family

ID=36579843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06734312T ATE515579T1 (de) 2005-02-02 2006-02-02 Hpv-e6-, -e7-mrna-test und verwendungsverfahren dafür

Country Status (9)

Country Link
US (7) US7524631B2 (de)
EP (2) EP2258877B1 (de)
JP (2) JP5184097B2 (de)
AT (1) ATE515579T1 (de)
AU (1) AU2006210483A1 (de)
CA (1) CA2596792A1 (de)
ES (2) ES2581128T3 (de)
HK (1) HK1146946A1 (de)
WO (1) WO2006084155A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063065A2 (en) 2004-12-08 2006-06-15 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
US7524631B2 (en) * 2005-02-02 2009-04-28 Patterson Bruce K HPV E6, E7 mRNA assay and methods of use thereof
US20090081688A1 (en) * 2005-06-20 2009-03-26 Advanced Cell Diagnostics Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
ES2511218T5 (es) * 2005-06-20 2017-12-07 Advanced Cell Diagnostics, Inc. Kits y productos para detección de ácidos nucleicos en células individuales y para identificación de células raras en grandes poblaciones de células heterogéneas
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8859218B2 (en) * 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
EP1997914A1 (de) * 2007-06-01 2008-12-03 Università Degli Studi Di Milano - Bicocca Identifizierung und Quantifizierung onkogener HPV-Nukleinsäuren mittels PCR-Assays in Echtzeit
CN102449479B (zh) 2009-05-07 2015-11-25 安科健康公司 鉴别高度或≥cin2用于人***瘤病毒(hpv)与hpv相关癌症的早期及晚期检测、筛检和诊断
WO2011046807A2 (en) * 2009-10-12 2011-04-21 Ventana Medical Systems, Inc. Multi-modality contrast and brightfield context rendering for enhanced pathology determination and multi-analyte detection in tissue
WO2011084598A1 (en) 2010-01-08 2011-07-14 Oncohealth Corporation High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers
EP2576840B1 (de) 2010-05-25 2018-10-17 QIAGEN Gaithersburg, Inc. Hybrid-capture-assay mit schneller ergebnislieferung und zugehörige strategisch gekürzte sonden
CN103429755A (zh) 2010-10-21 2013-12-04 领先细胞医疗诊断有限公司 用于原位检测核酸的超灵敏方法
CN107699618B (zh) * 2010-11-12 2021-08-20 茵赛德斯有限公司 非疾病诊断的确定宫颈上皮内瘤样(cin)细胞是否存在于来自受试者的标记液体宫颈细胞样本的方法和***
WO2012103414A2 (en) * 2011-01-28 2012-08-02 Advanced Cell Diagnostics, Inc. Rnascope® hpv assay for determining hpv status in head and neck cancers and cervical lesions
GB201310933D0 (en) * 2013-06-19 2013-07-31 Norchip As A method of cervical screening
US10308990B2 (en) 2014-07-25 2019-06-04 Incelldx, Inc. Methods of evaluating a cellular sample for latent cellular replication competent HIV-1
US20160177396A1 (en) * 2014-12-22 2016-06-23 Enzo Biochem, Inc. Comprehensive and comparative flow cytometry-based methods for identifying the state of a biological system
US20170204481A1 (en) * 2014-12-22 2017-07-20 Enzo Biochem, Inc. Comprehensive and comparative flow cytometry-based methods for identifying the state of a biological system
CN106555010A (zh) * 2015-09-30 2017-04-05 江苏博铼生技医疗科技有限公司 人类***瘤病毒检测试剂盒及检测方法
EP3913068B1 (de) 2015-10-12 2023-08-02 Advanced Cell Diagnostics, Inc. In-situ-detektion von nukleotidvarianten bei proben mit hohem rauschen sowie zugehörige zusammensetzungen und verfahren
SG10202100951SA (en) 2016-11-21 2021-03-30 Nanostring Technologies Inc Chemical compositions and methods of using same
GB201621912D0 (en) 2016-12-21 2017-02-01 Dublin Inst Of Tech And Trinity College Dublin A method of using raman spectroscopy for identification of low grade cervical cytology cases likely to progress to high grade / cancer
AU2019271028A1 (en) 2018-05-14 2020-12-03 Bruker Spatial Biology, Inc. Chemical compositions and methods of using same
CN109612800B (zh) * 2019-01-09 2021-12-21 济南金域医学检验中心有限公司 一种非妇科液基标本的制片方法
US11323413B2 (en) * 2019-08-29 2022-05-03 Oracle International Corporation Methods, systems, and computer readable media for actively discovering and tracking addresses associated with 4G service endpoints
US11082393B2 (en) * 2019-08-29 2021-08-03 Oracle International Corporation Methods, systems, and computer readable media for actively discovering and tracking addresses associated with 5G and non-5G service endpoints
CN113052806B (zh) * 2021-03-15 2023-02-28 黑龙江机智通智能科技有限公司 一种癌变程度分级***
US11895080B2 (en) 2021-06-23 2024-02-06 Oracle International Corporation Methods, systems, and computer readable media for resolution of inter-network domain names

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE3838269A1 (de) 1988-11-11 1990-05-17 Behringwerke Ag Nachweis humaner papillomavirus dna und ihrer expression in zervix-abstrichen
EP0502994B1 (de) 1989-12-01 1995-09-06 Amoco Corporation Detektion von hpv-transkripts
AU6945694A (en) 1993-05-06 1994-12-12 Dade International Inc. Human papillomavirus detection assay
AU726047B2 (en) 1995-11-15 2000-10-26 Gen-Probe Incorporated Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
CA2313641A1 (en) 1997-12-12 1999-06-24 Digene Corporation Universal collection medium
BRPI0214741B1 (pt) * 2001-12-08 2015-05-12 Seegene Inc Iniciador de controle de anelamento para melhorar a especificidade de anelamento na amplificação de ácido nucléico, Kit, Métodos para amplificar seqüências de ácido nucléico de um DNA e seqüência de ácido nucléico alvo ou uma mistura de ácidos nucléicos, para detectar a complementaridade de DNA ao mRNA diferencialmente expresso em duas ou mais amostras de ácido nucléico, para amplificar rapidamente um fragmento de CDNA alvo, para amplificar uma população de CDNAs de filamento duplo de comprimento completo complementar aos mRNAS, e CDNAs de filamento duplo enriquecidos em 5’ complementares aos mRNAS, para amplificar mais do que uma seqüência de nucleotídeo alvo simultaneamente, para produzir uma impressão digital de DNA de gDNA, e de RNA de uma amostra de mRNA, para identificar segmentos de homologia conservada em uma família de multigene a partir de uma amostra de mRNA, para identificar uma variação de nucleotídeo em um ácido nucléico alvo, para a mutagênese em um ácido nucléico alvo, e, uso do iniciador
US7326577B2 (en) * 2003-10-20 2008-02-05 Esoterix, Inc. Cell fixation and use in phospho-proteome screening
US7524631B2 (en) * 2005-02-02 2009-04-28 Patterson Bruce K HPV E6, E7 mRNA assay and methods of use thereof

Also Published As

Publication number Publication date
EP1848828B1 (de) 2011-07-06
EP1848828A1 (de) 2007-10-31
US7524631B2 (en) 2009-04-28
WO2006084155A1 (en) 2006-08-10
ES2369615T3 (es) 2011-12-02
HK1146946A1 (zh) 2011-07-22
ES2581128T3 (es) 2016-08-31
JP5184097B2 (ja) 2013-04-17
US20090220945A1 (en) 2009-09-03
US7888032B2 (en) 2011-02-15
US20100120021A1 (en) 2010-05-13
US20230287526A1 (en) 2023-09-14
US20140193805A1 (en) 2014-07-10
JP2008528058A (ja) 2008-07-31
EP2258877A3 (de) 2011-10-19
JP5773955B2 (ja) 2015-09-02
JP2012196229A (ja) 2012-10-18
US20170067127A1 (en) 2017-03-09
US9464332B2 (en) 2016-10-11
US8653250B2 (en) 2014-02-18
CA2596792A1 (en) 2006-08-10
US20060172285A1 (en) 2006-08-03
AU2006210483A1 (en) 2006-08-10
EP2258877A2 (de) 2010-12-08
EP2258877B1 (de) 2016-04-13
US20180230556A1 (en) 2018-08-16

Similar Documents

Publication Publication Date Title
ATE515579T1 (de) Hpv-e6-, -e7-mrna-test und verwendungsverfahren dafür
Fábián et al. Salivary genomics, transcriptomics and proteomics: the emerging concept of the oral ecosystem and their use in the early diagnosis of cancer and other diseases
Mirzamani et al. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization
WO2006075245A3 (en) Systems, methods, and compositions for detection of human papilloma virus in biological samples
WO2003048300A3 (en) Methods of identifying cellular target molecules
PT1687609E (pt) Sondas fluorescentes para a detecção de adn por hibridação com uma maior sensibilidade e menor ruído de fundo
US6420106B1 (en) Method and kit for early cancer prediction
De Koning et al. Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma
Mlakar et al. Morphological characteristics of conjunctival squamous papillomas in relation to human papillomavirus infection
Shah et al. HPV DNA is associated with a subset of Schneiderian papillomas but does not correlate with p16 INK4a immunoreactivity
Lukaszuk et al. HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study
ATE476440T1 (de) Hybridisierung von pna-sonden in alkohollösungen
ITMO20040126A1 (it) Sistema per la ricerca ed identificazione di agenti patogeni
Tsang et al. Detection of Epstein‐Barr Virus–Derived Latent Membrane Protein‐1 Gene in Various Head and Neck Cancers: Is It Specific for Nasopharyngeal Carcinoma?
Cina et al. Isolation and identification of male and female DNA on a postcoital condom
Cochand‐Priollet et al. Cost‐effectiveness of liquid‐based cytology with or without hybrid‐capture II HPV test compared with conventional Pap smears: a study by the French society of clinical cytology
CA2367833C (en) Method and kit for early cancer prediction
CN102209793B (zh) 用于检测hpv的核苷酸序列、方法和试剂盒
EP1056766A4 (de) Nachweis des humanen papilloma-virus mit hilfe des papanicolau-tests
Sancer et al. Comparison of DNA damage and proliferative capacities in smear samples of HPV positive and negative patients by micronucleus counting and AgNOR staining
BRPI0417699A (pt) métodos para detectar biomarcadores em uma amostra biológica, para detectar biomarcadores de cáncer ovariano em um esfregaço de pap e para detectar biomarcadores de cáncer endometrial em um esfregaço de pap
EP1829978A4 (de) Verfahren zum nachweis von genmethylierung und verfahren zur untersuchung von neoplasma mittels methylierungsnachweis
Chung et al. Comparison of the AdvanSure HPV GenoBlot assay with the INNO-LiPA HPV Genotyping assay for human papillomavirus genotyping
Perera et al. Impact of gamma herpes viruses status on established risk factor profile of oral squamous cell carcinoma tissues in a group of Sri Lankan male patients
Hjalmar Sequential Fluorescence In Situ Hybridization Analysis for Trisomy 12 in B-Cell Chronic Lymphocytic Leukemia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1848828

Country of ref document: EP